Oncology and Related Pharmaceutical Supply Procurement for Armed Forces Medical Service

Work Description - NA

This tender, bid number GEM/2026/B/7790246, is being issued by the Directorate General of Armed Forces Medical Service, under the Ministry of Defence, with an office located in KANGRA. The bidding period commences on 17-07-2026 at 7:34 PM and concludes on 05-08-2026 at 3:00 PM. This tender seeks to procure a comprehensive range of pharmaceutical supplies categorized under oncology and related treatments, encompassing a total quantity of 42,552 units. The specific items required include, but are not limited to, Abiraterone Acetate 500 mg tablets, Acalabrutinib 100 mg capsules, Afatinib 30 mg tablets, Anastrozole 1 mg tablets, Apalutamide 40 mg tablets, Axitinib 5 mg tablets, Azacitidine 300 mg tablets, Bevacizumab (300 mg and 400 mg injections), Cabergoline 0.5 mg tablets, Cabozantinib (20 mg and 40 mg tablets), Capecitabine 500 mg tablets, Carboplatin 450 mg injections, Cisplatin (10 mg and 50 mg injections), Dasatinib 50 mg tablets, Degarelix (120 mg and 80 mg injections), Denosumab solution 60 mg/ml injections, Eltrombopag 25 mg tablets, Enzalutamide (160 mg and 80 mg tablets), Erlotinib 150 mg tablets, Everolimus (0.25 mg, 0.5 mg, and 5 mg tablets), Exemestane 25 mg tablets, Gefitinib 250 mg tablets, Gemcitabine (1 gm and 200 mg injections), Infliximab 200 mg injections, Lenalidomide (10 mg and 25 mg tablets, and 5 mg capsules), Lenvatinib (10 mg and 4 mg tablets), Letrozole 2.5 mg tablets, Leuprolide Acetate (11.25 mg and 22.5 mg injections), Olaparib 300 mg tablets, Oxaliplatin (100 mg and 50 mg injections), Pazopanib 200 mg tablets, Pomalidomide 2 mg tablets, Relugolix 120 mg tablets, Rituximab (100 mg and 500 mg injections), Rucaparib 200 mg tablets, Tamoxifen (10 mg tablets and Citrate 20 mg tablets), and Temozolamide 20 mg tablets, as well as Tocilizumab 162mg 0.9ml injections. This tender aims to secure a reliable supply of these critical medications for the Armed Forces Medical Service.